Home/Bicara Therapeutics/Claire Mazumdar
CM

Claire Mazumdar

Chief Executive Officer

Bicara Therapeutics

Therapeutic Areas

Bicara Therapeutics Pipeline

DrugIndicationPhase
BCA101Head and Neck Squamous Cell Carcinoma (HNSCC)Phase 1/2